MIRA PHARMACEUTICALS INCMM

MIRA PHARMACEUTICALS INC

1.15EURR
+0.02+1.77%
As of today at 17:13 GMT
EUR
No trades
See on Supercharts

Price target

13.60REUR+12.45+1,083.00%
The 3 analysts offering 1 year price forecasts for MIRA PHARMACEUTICALS INC have a max estimate of 17.15 and a min estimate of 7.24.

Analyst rating

Based on 2 analysts giving stock ratings to MIRA PHARMACEUTICALS INC in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
1
Buy
0
Hold
1
Sell
0
Strong sell
0

EPS

Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪−0.28‬
‪−0.21‬
‪−0.14‬
‪−0.07‬
‪0.00‬
Reported
Estimate
Currency: EUR
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪−0.09‬
‪−0.26‬
‪−0.11‬
‪−0.10‬
‪−0.13‬
‪−0.23‬
Estimate
‪−0.25‬
‪−0.21‬
‪−0.08‬
‪−0.11‬
‪−0.14‬
‪−0.17‬
‪−0.13‬
‪−0.12‬
‪−0.14‬
‪−0.16‬
Surprise
−23.91%
−33.33%
+2.94%
+8.70%
−30.56%

Revenue

Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪0.00‬
Reported
Estimate
Currency: EUR
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
Estimate
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
Surprise
Be warned

Frequently Asked Questions


K6S EPS for the last quarter is −0.23 EUR despite the estimation of −0.17 EUR. In the next quarter EPS is expected to reach −0.13 EUR. Track more of MIRA PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter MIRA PHARMACEUTICALS INC revenue is expected to reach 0.00 EUR. Check out MIRA PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, K6S price target is 13.60 EUR with a max estimate of 17.15 EUR and a min estimate of 7.24 EUR. Check if this forecast comes true in a year, meanwhile watch MIRA PHARMACEUTICALS INC stock price chart and keep track of the current situation with K6S news and stock market news.